Abstract Cancer nanomedicine offers programmable platforms for diagnosis, imaging, drug and gene delivery, and theranostics, but its clinical performance is constrained by tumor heterogeneity, complex nano–bio interactions, and interpatient variability. Artificial intelligence (AI) provides a means to integrate physico...
Ruba Altahla, Yong-Ping Wang, Mahdi Morshedi Yekta et al.· International Journal of Nan...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.